Clinical Trials Logo
  1. Home
  2. Down Syndrome
  3. NCT02864108
  4. Details
NCT02864108 Clinical Trial

The Crnic Institute Human Trisome Project Biobank

Down Syndrome Clinical Trial

— HTP  

Official title:
Research to Develop the Human Trisome Project Biobank

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02864108
Other study ID # 15-2170
Secondary ID UL1TR001082
Status Recruiting
Phase
First received
Last updated
Start date July 2016
Est. completion date July 2036

Study information
Verified date April 2024
Source University of Colorado, Denver
Contact Angela Rachubinski, PhD
Phone (303) 724-7366
Email dsresearch@cuanschutz.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Human Trisome Project will significantly increase the speed of Down syndrome research and the understanding of associated medical conditions. Its biobank will provide de-identified samples to research.

Description:

The purpose of this study is to provide qualified and approved researchers with access to biological samples and health information to answer specific research questions. This project will significantly increase the speed of Down syndrome research and the understanding of associated medical conditions such as Alzheimer's disease, congenital heart defects, autoimmune disorders, autism, and some forms of leukemia. Participation includes a blood draw, a mouth swab, and allowing researchers to look at your health information yearly for the next 5 years. Optional procedures include providing a urine and/or stool sample and taking part in the study for a longer time frame.

Recruitment information / eligibility
Status Recruiting
Enrollment 2500
Est. completion date July 2036
Est. primary completion date July 2036
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 89 Years
Eligibility Inclusion Criteria: Anyone 6 months to 89 years old who: 1. has Down syndrome (any type) 2. does not have Down syndrome Exclusion Criteria: 1. Prisoners 2. Wards of the state

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Linda Crnic Institute for Down Syndrome at the University of Colorado Denver Denver Colorado

Sponsors (5)
Lead Sponsor Collaborator
University of Colorado, Denver Anna and John J. Sie Foundation, GLOBAL Down Syndrome Foundation, Linda Crnic Institute for Down Syndrome, National Center for Advancing Translational Sciences (NCATS)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of Participants and Controls Enrolled in Biobank Create biobank of blood cells and plasma, saliva, mouth swab, urine, stool, and induced pluripotent stem cells (iPSC) cells for use in approved research projects. 5 years
Secondary Number of Clinical Records Available for Approved Research Purposes Create a database of clinical information to pair with biological samples listed above. 5 years
Secondary Multidimensional Sample Characterization Characterize biological samples with multidimensional cellular and molecular analyses to generate the most thoroughly characterized set of samples from individuals with Down syndrome in the world. 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT04854122 - Blood Flow Regulation in Individuals With Down Syndrome - Training Study N/A
Completed NCT04020302 - Self-Monitoring Shopping Intervention N/A
Recruiting NCT01950624 - DS-Connect {TM}: The Down Syndrome Registry
Completed NCT04751136 - the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome Phase 2
Completed NCT04767412 - Inspiratory Muscle Training and Physical Fitness in Children With Down Syndrome Randomized Control Trial N/A
Not yet recruiting NCT04037579 - Protocol for a Non-randomized Survey in Down Syndrome People Who Practice Sports. Self and Observers´ Perception.
Completed NCT04536506 - Bobath and Vojta Therapy for DS N/A
Completed NCT02882698 - Performance Analysis in Down Syndrome on Mobile Phone N/A
Completed NCT01791725 - A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia Phase 2
Unknown status NCT01975545 - Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21 Phase 2
Completed NCT01808508 - Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome N/A
Terminated NCT00754013 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 Phase 3
Terminated NCT00754052 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 Phase 3
Completed NCT01313325 - Hippotherapy to Improve the Balance of Children With Movement Disorders N/A
Completed NCT01256112 - Parent Supported Weight Reduction in Down Syndrome N/A
Completed NCT01594346 - Multicenter Vitamin E Trial in Aging Persons With Down Syndrome Phase 3
Completed NCT05343468 - Life Skills Improved in Children With Down Syndrome After Using Assistive Technology N/A
Suspended NCT05755464 - Evaluation of Patients With Down Syndrome Compliance to Dental Therapy
Recruiting NCT04022460 - Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
Completed NCT04818437 - Effect of Core Stability Exercises and Balance Training in Postural Control Among Down Syndrome N/A

External Links